Literature DB >> 3556339

Achlorhydria: hypergastrinaemia: carcinoids--a flawed hypothesis?

J Penston, K G Wormsley.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1987        PMID： 3556339      PMCID： PMC1432809          DOI： 10.1136/gut.28.4.488

Source DB:  PubMed          Journal:  Gut        ISSN： 0017-5749            Impact factor:   23.059


× No keyword cloud information.
  149 in total

1.  Effect of selective proximal vagotomy on food-stimulated gastric acid secretion and gastrin release in patients with duodenal ulcer.

Authors:  M Feldman; R M Dickerman; R N McClelland; K A Cooper; J H Walsh; C T Richardson
Journal:  Gastroenterology       Date:  1979-05       Impact factor: 22.682

2.  Plasma gastrin and gastric enterochromaffinlike cell activation and proliferation. Studies with omeprazole and ranitidine in intact and antrectomized rats.

Authors:  H Larsson; E Carlsson; H Mattsson; L Lundell; F Sundler; G Sundell; B Wallmark; T Watanabe; R Håkanson
Journal:  Gastroenterology       Date:  1986-02       Impact factor: 22.682

3.  Effect of oral omeprazole on serum gastrin and serum pepsinogen I levels.

Authors:  H P Festen; J C Thijs; C B Lamers; J M Jansen; G Pals; R R Frants; J Défize; S G Meuwissen
Journal:  Gastroenterology       Date:  1984-11       Impact factor: 22.682

4.  Experimental gastric carcinogenesis in the rat: effects of hypergastrinemia and acid secretion.

Authors:  C W Deveney; H Freeman; L W Way
Journal:  Am J Surg       Date:  1980-01       Impact factor: 2.565

5.  Cell-kinetic investigations in the operated rat stomach to show the influence of duodenogastric reflux. An experimental long-term study.

Authors:  P Langhans; M Bues; R A Heger; J Hohenstein; K H Korfsmeier
Journal:  Scand J Gastroenterol Suppl       Date:  1984

6.  Composite gastric carcinoid and adenocarcinoma.

Authors:  M H Ali; A Davidson; J G Azzopardi
Journal:  Histopathology       Date:  1984-05       Impact factor: 5.087

Review 7.  Neuroendocrine components of the bronchopulmonary tract: hyperplasias, dysplasias, and neoplasms.

Authors:  V E Gould; R I Linnoila; V A Memoli; W H Warren
Journal:  Lab Invest       Date:  1983-11       Impact factor: 5.662

8.  Peripheral lung carcinoid tumor producing predominantly gastrin-releasing peptide (GRP). Morphologic and hormonal studies.

Authors:  S Tamai; T Kameya; K Yamaguchi; N Yanai; K Abe; N Yanaihara; H Yamazaki; K Kageyama
Journal:  Cancer       Date:  1983-07-15       Impact factor: 6.860

9.  Gastric carcinogenesis induced by N-methyl-N'-nitro-N-nitrosoguanidine: role of gastrectomy and duodenal reflux.

Authors:  R J Salmon; S Merle; B Zafrani; J J Decosse; P Sherlock; E E Deschner
Journal:  Jpn J Cancer Res       Date:  1985-03

10.  Solid carcinomas of the stomach. A combined histochemical, light and electron microscopic study.

Authors:  H Murayama; T Imai; M Kikuchi
Journal:  Cancer       Date:  1983-05-01       Impact factor: 6.860
View more
  24 in total

1.  Duodenal carcinoid tumour in a patient with rheumatoid arthritis receiving long term ranitidine treatment.

Authors:  P D Duane; T M Shallcross; R V Heatley
Journal:  BMJ       Date:  1990-01-13

2.  1976 and all that!--20 years of antisecretory therapy.

Authors:  A Garner; H Fadlallah; M E Parsons
Journal:  Gut       Date:  1996-12       Impact factor: 23.059

Review 3.  Histamine H2-receptor antagonists versus prostaglandins in the treatment of peptic ulcer disease.

Authors:  J G Penston; K G Wormsley
Journal:  Drugs       Date:  1989-04       Impact factor: 9.546

4.  Rebound nocturnal hypersecretion after four weeks treatment with an H2 receptor antagonist.

Authors:  G M Fullarton; G McLauchlan; A Macdonald; G P Crean; K E McColl
Journal:  Gut       Date:  1989-04       Impact factor: 23.059

5.  Do H2 receptor antagonists have to be given at night? A study of the antisecretory profile of SKF 94482, a new H2 receptor antagonist which has a profound effect on daytime acidity.

Authors:  S G Chiverton; D W Burget; R H Hunt
Journal:  Gut       Date:  1989-05       Impact factor: 23.059

6.  Serum gastrin concentration affects the self replication rate of the enterochromaffin like cells in the rat stomach.

Authors:  Y Tielemans; J Axelson; F Sundler; G Willems; R Håkanson
Journal:  Gut       Date:  1990-03       Impact factor: 23.059

7.  Gastric enterochromaffin-like (ECL) cells in hypergastrinaemic duodenal ulcer disease.

Authors:  M Coupe; H Rees; C J Springer; A E Bishop; J A Morris; J M Polak; J Calam
Journal:  Gut       Date:  1990-02       Impact factor: 23.059

8.  Rapid induction of enterochromaffinlike cell tumors by histamine2-receptor blockade.

Authors:  O Nilsson; B Wängberg; L Johansson; E Theodorsson; A Dahlström; I M Modlin; H Ahlman
Journal:  Am J Pathol       Date:  1993-04       Impact factor: 4.307

9.  Gastric autoimmune disorders in patients with chronic hepatitis C before, during and after interferon-alpha therapy.

Authors:  Carlo Fabbri; M Francesca Jaboli; Silvia Giovanelli; Francesco Azzaroli; Alessandro Pezzoli; Esterita Accogli; Stefania Liva; Giovanni Nigro; Anna Miracolo; Davide Festi; Antonio Colecchia; Marco Montagnani; Enrico Roda; Giuseppe Mazzella
Journal:  World J Gastroenterol       Date:  2003-07       Impact factor: 5.742

10.  Detection of anti-HAV antibody with dot immunogold filtration assay.

Authors:  Zhong-Jun Shao; De-Zhong Xu; Yong-Ping Yan; Jing-Hua Li; Jing-Xia Zhang; Zhi-Ying Zhang; Bo-Rong Pan
Journal:  World J Gastroenterol       Date:  2003-07       Impact factor: 5.742
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.